股本结构
单位:万股
公告日期 | 2024-03-07 | 2024-03-07 | 2023-11-09 | 2023-11-09 | 2023-08-10 | 2023-08-10 |
---|---|---|---|---|---|---|
证券总股本 | 13814.81 | 13814.35 | 13534.10 | 13533.98 | 13517.34 | 11415.05 |
普通股本 | 13814.81 | 13814.35 | 13534.10 | 13533.98 | 13517.34 | 11415.05 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-03-07 | 2023-12-31 | 2023-11-09 | 2023-09-30 | 2023-08-10 | 2023-06-30 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-03-07 | 13814.81 | 未披露 | 定期报告 | 2024-03-07 |
2024-03-07 | 13814.35 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common stock and pre-funded warrants in registered direct offering, net of offering cost
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
Repurchase of shares for minimum tax withholdings
Issuance of common stock upon at the market offerings, net
|
2023-12-31 |
2023-11-09 | 13534.10 | 未披露 | 定期报告 | 2023-11-09 |
2023-11-09 | 13533.98 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock and pre-funded warrants in registered direct offering, net of offering costs
Repurchase of shares for minimum tax withholdings
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
|
2023-09-30 |
2023-08-10 | 13517.34 | 未披露 | 定期报告 | 2023-08-10 |
2023-07-13 | 13506.61 | 未披露 |
更多>>
Common stock offered 21,000,000 shares by the company
|
2023-07-17 |
2023-08-10 | 11415.05 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
Repurchase of shares for minimum tax withholdings
|
2023-06-30 |
2023-05-15 | 11406.61 | 未披露 | 定期报告 | 2023-05-15 |
2023-03-30 | 11406.47 | 未披露 | 定期报告 | 2023-03-30 |
2023-03-30 | 11404.63 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Repurchase of shares for minimum tax withholdings
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
|
2022-12-31 |
2022-11-10 | 11404.40 | 未披露 | 定期报告 | 2022-11-10 |
2022-08-11 | 11404.26 | 未披露 | 定期报告 | 2022-08-11 |
2022-05-11 | 11404.13 | 未披露 | 定期报告 | 2022-05-11 |
2022-03-30 | 11403.99 | 未披露 | 定期报告 | 2022-03-30 |
2022-03-30 | 11403.69 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock and pre-funded warrants in public offering, net of offering costs
Repurchase of outstanding pre-funded warrants
Issuance of common stock upon exercise of stock warrants, net
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
Repurchase of shares for minimum tax withholdings
Stock-based compensation
|
2021-12-31 |
2021-11-12 | 11386.88 | 未披露 | 定期报告 | 2021-11-12 |
2021-11-12 | 11386.70 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
|
2021-09-30 |
2021-08-12 | 11384.78 | 未披露 | 定期报告 | 2021-08-12 |
2021-07-06 | 11385.03 | 未披露 | 定期报告 | 2021-07-01 |
2021-08-12 | 11384.75 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
|
2021-06-30 |
2021-05-13 | 11364.33 | 未披露 | 定期报告 | 2021-05-13 |
2021-05-13 | 11357.87 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of common stock and pre-funded warrants in public offering, net of offering costs
Net issuance of common stock upon exercise of stock warrants, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
|
2021-03-31 |
2021-03-15 | 9993.88 | 未披露 |
更多>>
1.Common stock offered by the company 45,785,828 shares.
2.The number of shares of common stock to be outstanding following this offering is based on 54,152,955 shares issued and outstanding at December 31, 2020.
|
2021-03-15 |
2021-03-10 | 5420.00 | 未披露 | 定期报告 | 2021-03-10 |
2021-03-10 | 5423.59 | 未披露 | 定期报告 | 2021-03-08 |
2021-03-10 | 5415.30 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock for licensing of assets
Issuance of common stock upon at the market offerings, net
Issuance of common stock upon exercise of Milestone Warrants, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
|
2020-12-31 |
2020-11-05 | 5414.13 | 未披露 | 定期报告 | 2020-11-04 |
2020-11-05 | 5413.92 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock upon exercise of Milestone Warrants, net
Issuance of common stock for settlement of RSUs
|
2020-09-30 |
2020-08-06 | 5412.85 | 未披露 | 定期报告 | 2020-08-06 |
2020-08-06 | 5282.33 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock for licensing of assets
Issuance of common stock upon at the market offerings, net
Issuance of common stock upon exercise of stock options
|
2020-06-30 |
2020-05-07 | 5218.71 | 未披露 | 定期报告 | 2020-05-04 |
2020-05-07 | 5084.45 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
|
2020-03-31 |
2020-04-15 | 5084.26 | 未披露 | 定期报告 | 2020-03-30 |
2020-03-12 | 5083.89 | 未披露 | 定期报告 | 2020-03-12 |
2020-03-12 | 5079.04 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of securities in private placement, net closing costs
Issuance of common stock upon at the market sales, net
Issuance of common stock upon settlement of contingent liability
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of warrants
Issuance of common stock upon exercise of stock options
|
2019-12-31 |
2019-11-07 | 4121.04 | 未披露 | 定期报告 | 2019-11-07 |
2019-11-07 | 4120.83 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common stock upon at the market offerings, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
|
2019-09-30 |
2019-08-08 | 4119.76 | 未披露 | 定期报告 | 2019-08-08 |
2019-08-08 | 3890.38 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Issuance of common stock upon at the market offerings, net
Issuance of common stock upon settlement of contingent liability
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of warrants
Issuance of common stock upon exercise of stock options
|
2019-06-30 |
2019-05-09 | 3772.11 | 未披露 | 定期报告 | 2019-05-09 |
2019-05-09 | 3583.02 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of common stock upon at the market offerings, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
|
2019-03-31 |
2019-03-13 | 3533.64 | 未披露 | 定期报告 | 2019-03-13 |
2019-03-13 | 3514.61 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common stock upon public offering, net closing costs
Issuance of common stock upon at the market offerings, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
Common stock issued for acquisition of assets
|
2018-12-31 |
2018-11-07 | 3512.88 | 未披露 | 定期报告 | 2018-11-07 |
2018-11-07 | 3512.05 | 未披露 |
更多>>
from December 31, 2017 to September 30, 2018
Issuance of common stock upon public offering, net
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
Common stock issued for purchase of assets
|
2018-09-30 |
2018-08-09 | 3509.43 | 未披露 | 定期报告 | 2018-08-09 |
2018-08-09 | 3083.68 | 未披露 |
更多>>
From December 31, 2017 to June 30, 2018
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
Common stock issued for purchase of assets
|
2018-06-30 |
2018-05-09 | 3060.69 | 未披露 | 定期报告 | 2018-05-09 |
2018-05-09 | 3060.44 | 未披露 |
更多>>
From December 31, 2017 to March 31, 2018
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
|
2018-03-31 |
2018-03-14 | 3059.67 | 未披露 | 定期报告 | 2018-03-14 |
2018-03-14 | 3050.95 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Repurchase of forfeited restricted common stock
Issuance of common stock upon exercise of warrants
Conversion of convertible notes into common stock
Conversion of redeemable convertible preferred stock to common stock as effected for the reverse merger exchange ratio
Business combination upon Merger
Issuance of common stock upon public offering, net closing costs
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
|
2017-12-31 |
2017-11-08 | 3050.07 | 未披露 |
更多>>
On October 27, 2017, the Company completed an underwritten public offering consisting of 5,250,000 shares of its common stock, in addition to pre-funded warrants to purchase 775,000 shares of its common stock.Under the offering, the underwriter was granted an option to purchase 787,500 additional shares of Savara common stock at the public offering price,less the underwriting discounts and commissions. The underwriters’ option to purchase the remaining balance of additional shares expires 30 days from the date of the offering, or on November 24, 2017. On November 2, 2017, the underwriters exercised their option to purchase the 787,500 additional shares resulting in net proceeds of approximately $5.7 million.
|
2017-11-08 |
2017-11-08 | 2438.91 | 未披露 |
更多>>
From December 31, 2016 to September 30, 2017
Conversion of redeemable convertible preferred stock to common stock as effected for the reverse merger exchange ratio
Issuance of common stock upon exercise of warrants
Conversion of convertible notes into common stock
Business combination upon Merger
Issuance of common stock upon public offering, net closing costs
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
|
2017-09-30 |
2017-08-09 | 2420.35 | 未披露 |
更多>>
from December 31, 2016 to June 30, 2017
Repurchase of forfeited restricted common stock
Issuance of common stock upon exercise of warrants
Conversion of convertible notes into common stock
Conversion of redeemable convertible preferred stock to common stock as effected for the reverse merger exchange ratio
Business combination upon Merger
Issuance of common stock upon public offering, net closing costs
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
|
2017-06-30 |
2017-05-09 | 1515.33 | 未披露 | 定期报告 | 2017-05-05 |
2017-05-09 | 363.92 | 未披露 |
更多>>
giving effect to the 1-for-70 reverse stock split that was implemented on April 27, 2017
|
2017-04-27 |
2015-05-11 | 16307.18 | 未披露 | 定期报告 | 2015-05-06 |
2015-04-29 | 15962.81 | 未披露 | 定期报告 | 2015-04-17 |
2015-05-11 | 15947.62 | 未披露 | 定期报告 | 2015-03-31 |
2015-03-24 | 15945.84 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Sale of common stock and pre-funded warrants, net of offering costs of $2,095
Issuance of stock in Aires acquisition
Warrant exercise
|
2014-12-31 |
2014-10-31 | 12851.73 | 未披露 | 定期报告 | 2014-10-29 |
2014-10-31 | 12750.84 | 未披露 | 定期报告 | 2014-09-30 |
2014-08-11 | 11984.25 | 未披露 | 定期报告 | 2014-06-30 |
2014-04-29 | 11413.65 | 未披露 | 定期报告 | 2014-04-22 |
2014-05-05 | 11372.16 | 未披露 | 定期报告 | 2014-03-31 |
2014-03-26 | 11360.78 | 未披露 | 定期报告 | 2014-03-24 |
2014-03-26 | 10271.03 | 未披露 |
更多>>
From December 31,2012 to June 30, 2013
Sale of common stock, net of offering costs of $2,360,548
Issuance of stock pursuant to achievement of milestone in SynthRx acquisition
|
2013-06-30 |
2013-03-19 | 4626.53 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Exercise of stock options
Repurchase of Subject to Vesting Shares
|
2012-12-31 |
2012-11-05 | 4771.94 | 未披露 | 定期报告 | 2012-11-01 |
2012-03-08 | 4771.57 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Sale of common stock, net of offering costs of $1,548,123
Issuance of stock in SynthRx acquisition
Sale of common stock, net of offering costs of $1,355,196
|
2011-12-31 |
2011-05-09 | 2646.57 | 未披露 | 定期报告 | 2011-05-05 |
2011-03-10 | 1548.03 | 未披露 |
更多>>
from December 31, 2009 to December 31, 2010
Reduction of shares and cash paid in lieu for fractional shares following the reverse split
Conversion of series E preferred stock into common stock
Conversion of series F preferred stock into common stock
Series A warrants exercised
|
2010-12-31 |
From December 31,2022 to December 31,2023
Issuance of common stock and pre-funded warrants in registered direct offering, net of offering cost
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
Repurchase of shares for minimum tax withholdings
Issuance of common stock upon at the market offerings, net
From June 30, 2023 to September 30, 2023
Issuance of common stock and pre-funded warrants in registered direct offering, net of offering costs
Repurchase of shares for minimum tax withholdings
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
Common stock offered 21,000,000 shares by the company
From March 31, 2023 to June 30, 2023
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
Repurchase of shares for minimum tax withholdings
From December 31, 2021 to December 31, 2022
Repurchase of shares for minimum tax withholdings
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
From December 31, 2020 to December 31, 2021
Issuance of common stock and pre-funded warrants in public offering, net of offering costs
Repurchase of outstanding pre-funded warrants
Issuance of common stock upon exercise of stock warrants, net
Issuance of common stock upon exercise of stock options
Issuance of common stock for settlement of RSUs
Repurchase of shares for minimum tax withholdings
Stock-based compensation
From June 30, 2021 to September 30, 2021
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
From March 31, 2021 to June 30, 2021
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
From December 31, 2020 To March 31, 2021
Issuance of common stock and pre-funded warrants in public offering, net of offering costs
Net issuance of common stock upon exercise of stock warrants, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
1.Common stock offered by the company 45,785,828 shares.
2.The number of shares of common stock to be outstanding following this offering is based on 54,152,955 shares issued and outstanding at December 31, 2020.
From December 31, 2019 to December 31, 2020
Issuance of common stock for licensing of assets
Issuance of common stock upon at the market offerings, net
Issuance of common stock upon exercise of Milestone Warrants, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
From June 30, 2020 to September 30, 2020
Issuance of common stock upon exercise of Milestone Warrants, net
Issuance of common stock for settlement of RSUs
From March 31, 2020 to June 30, 2020
Issuance of common stock for licensing of assets
Issuance of common stock upon at the market offerings, net
Issuance of common stock upon exercise of stock options
From December 31, 2019 to March 31, 2020
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
From December 31, 2018 to December 31, 2019
Issuance of securities in private placement, net closing costs
Issuance of common stock upon at the market sales, net
Issuance of common stock upon settlement of contingent liability
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of warrants
Issuance of common stock upon exercise of stock options
from June 30, 2019 to September 30, 2019
Issuance of common stock upon at the market offerings, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon exercise of stock options
from March 31, 2019 to June 30,2019
Issuance of common stock upon at the market offerings, net
Issuance of common stock upon settlement of contingent liability
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of warrants
Issuance of common stock upon exercise of stock options
from December 31, 2018 to March 31, 2019
Issuance of common stock upon at the market offerings, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
from December 31, 2017 to December 31, 2018
Issuance of common stock upon public offering, net closing costs
Issuance of common stock upon at the market offerings, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
Common stock issued for acquisition of assets
from December 31, 2017 to September 30, 2018
Issuance of common stock upon public offering, net
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
Common stock issued for purchase of assets
From December 31, 2017 to June 30, 2018
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
Common stock issued for purchase of assets
From December 31, 2017 to March 31, 2018
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of warrants
from December 31, 2016 to December 31, 2017
Repurchase of forfeited restricted common stock
Issuance of common stock upon exercise of warrants
Conversion of convertible notes into common stock
Conversion of redeemable convertible preferred stock to common stock as effected for the reverse merger exchange ratio
Business combination upon Merger
Issuance of common stock upon public offering, net closing costs
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Net issuance of common stock upon cashless exercise of stock options
Issuance of common stock upon exercise of stock options
On October 27, 2017, the Company completed an underwritten public offering consisting of 5,250,000 shares of its common stock, in addition to pre-funded warrants to purchase 775,000 shares of its common stock.Under the offering, the underwriter was granted an option to purchase 787,500 additional shares of Savara common stock at the public offering price,less the underwriting discounts and commissions. The underwriters’ option to purchase the remaining balance of additional shares expires 30 days from the date of the offering, or on November 24, 2017. On November 2, 2017, the underwriters exercised their option to purchase the 787,500 additional shares resulting in net proceeds of approximately $5.7 million.
From December 31, 2016 to September 30, 2017
Conversion of redeemable convertible preferred stock to common stock as effected for the reverse merger exchange ratio
Issuance of common stock upon exercise of warrants
Conversion of convertible notes into common stock
Business combination upon Merger
Issuance of common stock upon public offering, net closing costs
Issuance of common stock upon At The Market sales, net
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
from December 31, 2016 to June 30, 2017
Repurchase of forfeited restricted common stock
Issuance of common stock upon exercise of warrants
Conversion of convertible notes into common stock
Conversion of redeemable convertible preferred stock to common stock as effected for the reverse merger exchange ratio
Business combination upon Merger
Issuance of common stock upon public offering, net closing costs
Issuance of common stock for settlement of RSUs
Issuance of common stock upon cashless exercise of stock options
giving effect to the 1-for-70 reverse stock split that was implemented on April 27, 2017
from December 31, 2013 to December 31, 2014
Sale of common stock and pre-funded warrants, net of offering costs of $2,095
Issuance of stock in Aires acquisition
Warrant exercise
From December 31,2012 to June 30, 2013
Sale of common stock, net of offering costs of $2,360,548
Issuance of stock pursuant to achievement of milestone in SynthRx acquisition
from December 31, 2011 to December 31, 2012
Exercise of stock options
Repurchase of Subject to Vesting Shares
from December 31, 2010 to December 31, 2011
Sale of common stock, net of offering costs of $1,548,123
Issuance of stock in SynthRx acquisition
Sale of common stock, net of offering costs of $1,355,196
from December 31, 2009 to December 31, 2010
Reduction of shares and cash paid in lieu for fractional shares following the reverse split
Conversion of series E preferred stock into common stock
Conversion of series F preferred stock into common stock
Series A warrants exercised